T1	Participants 128 154	In 1,002 men aged 45-80 y,
T2	Participants 418 556	This study was extended to 7,350 men using serum PSA and DRE as first approach, followed by TRUS only when 1 of these 2 tests was abnormal
T3	Participants 926 962	an unselected, unscreened population
